Home/Filings/4/0001213900-24-015465
4//SEC Filing

MARTELL RON 4

Accession 0001213900-24-015465

CIK 0001788028other

Filed

Feb 19, 7:00 PM ET

Accepted

Feb 20, 7:33 PM ET

Size

5.7 KB

Accession

0001213900-24-015465

Insider Transaction Report

Form 4
Period: 2024-02-15
MARTELL RON
DirectorPresident, CEO and Director
Transactions
  • Award

    Stock Option (right to buy)

    2024-02-15+100,000100,000 total
    Exercise: $17.95Exp: 2034-02-15Voting Common Stock (100,000 underlying)
Footnotes (1)
  • [F1]1/4th of the shares subject to the option shall vest on February 15, 2025, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.

Documents

1 file

Issuer

Jasper Therapeutics, Inc.

CIK 0001788028

Entity typeother

Related Parties

1
  • filerCIK 0001177079

Filing Metadata

Form type
4
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 7:33 PM ET
Size
5.7 KB